Wells Fargo’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2K | Hold |
725
| – | – | ﹤0.01% | 5211 |
|
|
2025
Q1 | $28.3K | Buy |
725
+400
| +123% | +$15.6K | ﹤0.01% | 5137 |
|
|
2024
Q4 | $17.6K | Buy |
325
+25
| +8% | +$1.35K | ﹤0.01% | 5302 |
|
|
2024
Q3 | $15.1K | Buy |
300
+200
| +200% | +$10.1K | ﹤0.01% | 5301 |
|
|
2024
Q2 | $4.4K | Hold |
100
| – | – | ﹤0.01% | 5509 |
|
|
2024
Q1 | $5.02K | Hold |
100
| – | – | ﹤0.01% | 5497 |
|
|
2023
Q4 | $6.04K | Hold |
100
| – | – | ﹤0.01% | 5489 |
|
|
2023
Q3 | $5.7K | Buy |
+100
| New | +$5.7K | ﹤0.01% | 5560 |
|